Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05778760 · ClinicalTrials.gov registry record · NA

Prospective Study of Topical Adapinoid Versus Topical Retinol

A NA study, sponsored by Integrative Skin Science and Research.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT05778760 is a NA study that has completed, run by Integrative Skin Science and Research. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05778760, a NA study, has completed, sponsored by Integrative Skin Science and Research.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

This study is to analyze and compare the effects of applying two topical vitamin-A derived ingredients on facial skin health, appearance and tolerability. One of these ingredients is retinol, and the other is Adapinoid, also known as Oleyl Adapalenate, a novel anti-aging ingredient.

Interventions

  • OTHER Retinol
  • OTHER Adapinoid

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2023-05-01
Est. Completion 2023-09-01
Phase NA

What the Registry Record Tells You About NCT05778760

The ClinicalTrials.gov registry entry for NCT05778760 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integrative Skin Science and Research, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Retinol is the first listed.

NCT05778760 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05778760 about?

NCT05778760 is a clinical study titled "Prospective Study of Topical Adapinoid Versus Topical Retinol". This study is to analyze and compare the effects of applying two topical vitamin-A derived ingredients on facial skin health, appearance and tolerability. One of these ingredients is retinol, and the other is Adapinoid, also known as Oleyl Adapalenate, a novel anti-aging ingredient.

What is the current status of trial NCT05778760?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2023-05-01. Estimated completion is 2023-09-01.

What interventions are being tested in trial NCT05778760?

The interventions under investigation include: Retinol (OTHER), Adapinoid (OTHER).

Who is sponsoring clinical trial NCT05778760?

This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.